UPDATE: Exact Sciences Q3 Revenues Flat, Net Loss Narrows | GenomeWeb

The story has been updated to include comments from Exact Sciences' conference call this morning.

NEW YORK (GenomeWeb News) – Exact Sciences today said that revenues for its third quarter were flat, while its net loss narrowed.

The company reported that for the three months ended Sept. 30, revenues remained at $1 million, in line with the average Wall Street estimate. All revenues were derived from licensing fees.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.